4:1 R2R trading opportunity

NASDAQ:EYPT   EyePoint Pharmaceuticals, Inc.
Prices taking support on an upward trend line. Fibonacci and previous major resistance levels support a likely 4:1 trading opportunity.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.